Andrew Goodman > Goodwin > New York, United States > Lawyer Profile
Goodwin Offices
THE NEW YORK TIMES BUILDING
620 EIGHTH AVENUE
NEW YORK NY 10018
NEW YORK
United States
- Firm Profile
- Go to...
Andrew Goodman
Position
Partner
Career
Andrew Goodman is a partner in Goodwin’s Technology and Life Sciences groups, and a member of its Public M&A/Corporate Governance practice and Shareholder Activism & Takeover Defense practice. His practice focuses on public company mergers and acquisitions, friendly and hostile M&A, corporate governance, shareholder activism defense, and contested situations. He works with clients in a variety of industries, including technology and life sciences.
Education
JD, 2002, Tulane University Law School (cum laude) / BA, 1999, University of Rochester (cum laude)
Lawyer Rankings
United States > M&A/corporate and commercial > Shareholder activism
Practitioners at Goodwin‘s Boston office have extensive experience in designing strategies to protect public companies across a plethora of industries and of varying sizes from activist action and hostile takeover bids. Its recent caseload has included defense against some of the largest activists funds. The practice is jointly led by Andrew Goodman, whose corporate governance practice is strong on change in control transactions and shareholder activism, and Joseph Johnson, who has a notable track record in advising public companies. Katherine Hand adds robust support.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Capital markets: debt offerings
- International trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade > Customs, export controls and economic sanctions
- Healthcare > Service providers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Shareholder activism